Colchicine Effect on Amyotrophic Lateral Sclerosis Patients | MicrobiomeTrials← Back to trialsNCT07813858
Colchicine Effect on Amyotrophic Lateral Sclerosis Patients
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-10Est. Completion: 2028-05
Enrollment target: 87 participants Locations- Centro Clinico Nemo, Milan, Milano, Italy
- CENTRO SLA, Ospedale Civile di Baggiovara, AOU Modena, Modena, Modena, Italy
- CENTRO SLA, AOU Università Degli Studi Della Campania Luigi Vanvitelli, Naples, Napoli, Italy
- CENTRO SLA, AOU Maggiore Della Carità, Novara, Novara, Italy
- CENTRO SLA, Fondazione Istituto Neurologico Nazionale Casimiro Mondino IRCCS, Pavia, Pavia, Italy
Other microbiome trials you might be interested in
Amyotrophic Lateral Sclerosis
Given the role of adaptive immunity in ALS, the pathogenicity of some clostridial strains on motorneurons, the putative …
Roma, ItalyCompleted Feb 1, 2025
Amyotrophic Lateral Sclerosis
PIONEER-ALS is a Phase 1/2, multicenter, open-label, ascending dose, uncontrolled, first-in-human study that will evalua…
Phoenix, United StatesEst. completion Oct 15, 2027